Showing 7371-7380 of 21432 results for "".
- Gastroenterologists Are Begging People to Pay Attention to the Side Effects of These 2 Common Vitaminshttps://reachmd.com/news/gastroenterologists-are-begging-people-to-pay-attention-to-the-side-effects-of-these-2-common-vitamins/2468179/Vitamin D and iron are two nutrients that many people in the U.S. don’t get enough of. One in four people in the U.S. don’t get enough vitamin D while
- Boosting Brain Protein Levels May Slow Decline from Alzheimer'shttps://reachmd.com/news/boosting-brain-protein-levels-may-slow-decline-from-alzheimers/2468158/A study published in the journal Brain shows that increases in protein levels with new Alzheimer's drugs can explain the slowing of cognitive impairment at least as well as the reduction in amyloid plaques. During a study challenging the idea that newly approved monoclona
- Pollution Harms Men's Fertility, But Traffic Noise Affects Women'shttps://reachmd.com/news/pollution-harms-mens-fertility-but-traffic-noise-affects-womens/2468183/Roughly one in six people are affected by infertility worldwide. And with more than half the world’s population now living in
- Fosgonimeton Small Molecule Therapy for Alzheimer’s Fails to Meet Study Endpointshttps://reachmd.com/news/fosgonimeton-small-molecule-therapy-for-alzheimers-fails-to-meet-study-endpoints/2468181/Athira Pharma (Bothwell, WA) reported results from the LIFT-AD clinical trial revealing that it’s investigational drug, fosgonimeton (ATH-1017), did not meet the study’s primary or key secondary endpoints as a treatment for mild to moderate Alzheimer disease (AD).
- Postpartum Women Prescribed More Benzodiazepine During COVIDhttps://reachmd.com/news/postpartum-women-prescribed-more-benzodiazepine-during-covid/2468175/Diagnoses of postpartum depression, anxiety and SSRI prescriptions didn’t increase during COVID-19 New research from the University of Georgia suggests the COVID-19 pandemic may have had an unexpected side effect for postpartum women
- New Consensus Statement for Diagnosis of Atypical Parkinsonian Disorders Publishedhttps://reachmd.com/news/new-consensus-statement-for-diagnosis-of-atypical-parkinsonian-disorders-published/2468184/A recent consensus statement published in Neurology Clinical Practice provides a differential diagnosis algorithm that may be helpful for use by general neurologists who are seeing patients with a potential atypical parkinsonian disorder (APD). The statement includes an
- Researchers Uncover Shared Cellular Mechanisms Across 3 Major Dementiashttps://reachmd.com/news/researchers-uncover-shared-cellular-mechanisms-across-3-major-dementias/2468160/Researchers have for the first time identified degeneration-associated “molecular markers” – observable changes in cells and their gene-regulating networks – that are shared by several forms of dementia that affect different regions of the brain. Critically, the
- Light Pollution a New Alzheimer's Risk Factorhttps://reachmd.com/news/light-pollution-a-new-alzheimers-risk-factor/2468161/Outdoor light at night could be a significant risk factor in Alzheimer's disease, according to new research from Rush. While light pollution is associated with increased risk of some disorders and diseases, this is the first time it had been associated with Alzheimer's di
- Machine Learning May Lead to Better Flu Vaccineshttps://reachmd.com/news/machine-learning-may-lead-to-better-flu-vaccines/2468143/NIAViD is a model for detecting antigenic transitions in influenza A (H3N2) without knowledge of cluster identity. This figure illustrates the computational workflow used to fit and valid
- Can Chatbots Help with Genetic Testing for Cancer Risk?https://reachmd.com/news/can-chatbots-help-with-genetic-testing-for-cancer-risk/2468148/In a study from Huntsman Cancer Institute at the